PLOD2 and metastatic malignant neoplasm in the lymph nodes: Similarly, our research showed that OSCC patients with higher PLOD2 in FLCs had worse tumor differentiation and WPOI and higher risk of lymph node metastasis compared with lower PLOD2FLCs.